Fig. 1. RNA sequencing demonstrating eIF4E-associated lncRNAs in tumor cells from MCL patients and MCL cell line.

a Fold change of top eight lncRNAs detected in RNA-IP using anti-eIF4E antibody in MCL tumor cells (n = 4) and Jeko cell line as compared to normal control (n = 3) are shown. b Enrichment analysis on the lncRNAs by comparing the mapped read counts in the RNA sample pulled down with ant-eIF4E antibody to total RNA samples in Jeko cell line. c SNHG12 was detected by RT-PCR after RNA-IP assay using eIF4E antibody in MCL cell lines (n = 3) Jeko, Mino, and Granta and normal control (n = 3). GAPDH was used as a control